ArticleClinical rheumatology2025
Clinical Characteristics, Imaging Patterns and Management in Male and Female Patients with Primary Sjögren's Syndrome-associated Interstitial Lung Disease.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The role of sequential biologic therapy in rheumatoid arthritis: a systematic review and meta-analysis of efficacy, safety, and predictive factors.Clinical rheumatology · 2025Pooled it
- Sex and gender differences in rheumatology: clinical impact and future directions.Nature reviews. Rheumatology · 2026Review
- Clinical, immunological, and radiological characteristics of pulmonary involvement in childhood-onset primary Sjögren's syndrome: a single-center retrospective study.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionThe influence of sex on primary Sjögren's disease-associated interstitial lung disease (pSjD-ILD) remains poorly understood. Therefore, we aimed to investigate the sex-related differences in the clinical characteristics and outcomes of pSjD-ILD.
methodsConsecutive patients with pSjD-ILD in Nanjing University Affiliated Drum Tower Hospital from November 2007 to November 2022 were enrolled. Demographics, comorbidities, laboratory parameters, imaging patterns, pulmonary function tests, and treatments were compared between male and female patients. Kaplan-Meier method was used to assess survival. Cox proportional hazards model was employed to identify prognostic factors.
resultsA total of 125 male and 433 female patients were enrolled. Male patients had a higher prevalence of pulmonary hypertension (33.0% vs 20.6%, p = 0.014), overall cancer (14.4% vs 6.7%, p = 0.006), and radiological usual interstitial pneumonia (UIP, 28.0% vs 16.2%, p = 0.003). They also had higher usage of antifibrotic drugs (24.8% vs 16.2%, p = 0.027). In contrast, female patients had higher positive rates for antinuclear antibody (83.6% vs 73.6%, p = 0.011) and anti-Ro52 antibody (59.8% vs 44.8%, p = 0.003). No differences existed in the total ESSDAI score between male and female patients. Follow-up data showed that male patients had higher 3-year (32.3% vs 18.0%, p = 0.003) and 5-year mortality (52.4% vs 35.0%, p = 0.006) compared to female patients. Multivariate Cox model indicated that age (HR 1.058, p < 0.001) and UIP (HR 1.874, p = 0.009) were significant prognostic factors.
conclusionsIn pSjD-ILD, male patients tend to have more severe pulmonary manifestations, higher frequencies of pulmonary hypertension and cancer, and poorer outcomes compared to female patients. Key points • Male pSjD-ILD patients were more likely to suffer from pulmonary hypertension and cancer than their female counterparts. • Radiological UIP pattern was more frequently observed in male patients with pSjD-ILD than in female patients. • Male patients with pSjD-ILD had higher 3-year and 5-year mortality than female patients.
Indexed as
Identifiers
40781169What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.